H. Kang

发表

Spatiotemporal genomic architecture informs precision oncology in glioblastoma

In-Hee Lee, Raul Rabadan, Chul-Kee Park, 2017, Nature Genetics.

Distinct genomic profile and specific targeted drug responses in adult cerebellar glioblastoma

Jason K. Sa, R. Rabadán, H. Seol, 2018, Neuro-oncology.

Unraveling the Transcriptomic Signatures of Homologous Recombination Deficiency in Ovarian Cancers

Jin-Ku Lee, Jinho Kim, H. Kang, 2022, Advanced biology.

Sphere-Forming Culture for Expanding Genetically Distinct Patient-Derived Glioma Stem Cells by Cellular Growth Rate Screening

H. Seol, Jung-Il Lee, D. Kong, 2020, Cancers.

Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy

Kyoung-Mee Kim, Raul Rabadan, Donggeon Kim, 2018, Nature Genetics.

Secretome analysis of patient-derived GBM tumor spheres identifies midkine as a potent therapeutic target

R. Rabadán, H. Seol, Jung-Il Lee, 2019, Experimental & Molecular Medicine.

Spatiotemporal genomic architecture informs precision oncology in glioblastoma

Daniel I. S. Rosenbloom, A. Iavarone, Pablo G. Cámara, 2017, Nature Genetics.

High-throughput organo-on-pillar (high-TOP) array system for three-dimensional ex vivo drug testing.

Sang Youl Jeon, Dong Woo Lee, Jung‐joo Choi, 2023, Biomaterials.

Spatiotemporal genomic architecture informs precision oncology in glioblastoma

Daniel I. S. Rosenbloom, A. Blumberg, A. Iavarone, 2017, Nature Genetics.

expHRD: an individualized, transcriptome-based prediction model for homologous recombination deficiency assessment in cancer

Donghyo Kim, H. Kang, Jae Jun Lee, 2024, BMC Bioinform..